# Ernexa Therapeutics Inc.: Form 8-K, filed Jan 5, 2022

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2022-01-05
- Accepted by EDGAR: Jan 5, 2022, 06:06 ET
- Period: 2022-01-03
- Accession: 0001140361-22-000588
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000114036122000588/brhc10032515_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000114036122000588/

## Items reported

- Item 2.05: Exit or disposal costs

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000114036122000588/brhc10032515_8k.htm

Filed Jan 5, 2022.
Source: SEC EDGAR, the filing index for accession 0001140361-22-000588. Last ingested by Listed: Nov 11, 2026, 02:49 ET. No prices; not investment advice.